Formycon AG (United States)

Formycon is a German biotechnology company developing high-quality biosimilar and biobetter medications. The company focuses on ophthalmology and immunology, developing biosimilar alternatives to expensive biologic drugs used in eye diseases and autoimmune conditions. Formycon’s biosimilars increase patient access to life-changing biologic therapies.